Long-Term Safety of Sonidegib in Basal Cell Carcinoma: 30-Month Results from the BOLT Trial

Main Article Content

Ragini Kudchadkar
Anne Lynn S Chang


sonidegib, basal cell carcinoma, hedgehog inhibitor, non-melanoma skin cancer, skin cancer


Abstract not available.


Disclosures: Study sponsored by SUN Pharma.


Copyright 2018 SKIN

Most read articles by the same author(s)